The natural history of chronic obstructive pulmonary disease

Pneumonologia i Alergologia Polska

Volumn 79, Issue 2, 2011, Pages 139-143

  Mannino, David M ^a  

^a UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; HOSPITALIZATION; HUMAN; PATHOPHYSIOLOGY; RISK FACTOR;

HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 79952341776     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Mannino D.M.,Buist A.S.,Vollmer W.M. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 200762:237-241. (Pubitemid 46579804)
2. Burrows B.,Strauss R.H.,Niden A.H. Chronic Obstructive Lung Disease.3. Interrelationships of pulmonary function data. Am. Rev. Respir. Dis.19659:861-868.
3. Fletcher C.,Peto R.,Tinker C. M. et al.The natural history of chronicbronchitis and emphysema.Oxford University Press,1976.
4. Peto R., Speizer F.E., Cochrane A.L. et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. Am. Rev. Respir. Dis. 1983; 128 491-500. (Pubitemid 13006153)
5. Anthonisen N.R. The British hypothesis revisited. Eur. Respir. J. 2004; 23 657-658.
6. Vestbo J., Prescott E. Update on the 'Dutch hypothesis' for chronic respiratory disease. Thorax 1998; 53 (Suppl. 2) S15- -S19.
7. Rabe K.F., Hurd S., Anzueto A. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007; 176 532-555. (Pubitemid 47403272)
8. Pellegrino R., Viegi G., Brusasco V. et al. Interpretative strategies for lung function tests. Eur. Respir. J. 2005; 26 948-968. (Pubitemid 41632054)
9. Celli B.R., MacNee W. Standards for the diagnosis and treatment of patients with COPD a summary of the ATS/ERS position paper. Eur. Respir. J. 2004; 23 932-946. (Pubitemid 38807371)
10. Swanney M.P., Ruppel G., Enright P.L. et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63 1046-1051.
11. Mannino D.M., Watt G., Hole D. et al. The global burden of chronic obstructive pulmonary disease, number 3, The natural history of chronic obstructive pulmonary disease. Eur. Respir. J. 2006; 27 627-643.
12. Buist A.S., McBurnie M.A., Vollmer W.M. et al. International variation in the prevalence of COPD (the BOLD study) a population- based prevalence study. Lancet 2007; 370 741-750. (Pubitemid 47321907)
13. Trupin L., Earnest G., San P.M. et al. The occupational burden of chronic obstructive pulmonary disease. Eur. Respir. J. 2003; 22 462-469. (Pubitemid 37098927)
14. Liu Y., Lee K., Perez-Padilla R. et al. Outdoor and indoor air pollution and COPD-related diseases in high- and low-income countries. Int. J. Tuberc. Lung Dis. 2008; 12 115-127. (Pubitemid 351212402)
15. Caramori G., Adcock I. Gene-environment interactions in the development of chronic obstructive pulmonary disease. Curr. Opin. Allergy Clin. Immunol. 2006; 6 323-328. (Pubitemid 44368237)
16. Barnes P.J. Medical progress Chronic obstructive pulmonary disease. N. Engl. J. Med. 2000; 343 269-280. (Pubitemid 30490396)
17. Marsh S.E., Travers J., Weatherall M. et al. Proportional classifications of COPD phenotypes. Thorax 2008; 63 761-767.
18. de Marco R., Accordini S., Cerveri I. et al. An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax 2004; 59 120-125. (Pubitemid 38223482)
19. Postma D.S., Lebowitz M.D. Persistence and new onset of asthma and chronic bronchitis evaluated longitudinally in a community population sample of adults. Arch. Intern. Med. 1995; 155 1393-1399.
20. Lange P., Parner J., Vestbo J. et al. A 15-year follow-up study of ventilatory function in adults with asthma. N. Engl. J. Med. 1998; 339 1194-1200.
21. Friedlander A.L., Lynch D., Dyar LA. et al. Phenotypes of chronic obstructive pulmonary disease. COPD 2007; 4 355-384. (Pubitemid 350135871)
22. Mannino D.M., Buist A.S. Global burden of COPD risk factors, prevalence, and future trends. Lancet 2007; 370 765-773. (Pubitemid 47321908)
23. Halbert R.J., Natoli J.L., Gano A. et al. Global burden of COPD systematic review and meta-analysis. Eur. Respir. J. 2006; 28 523-532. (Pubitemid 44794666)
24. Engstrom C.P., Persson L.O., Larsson S. et al. Health-related quality of life in COPD why both disease-specific and generic measures should be used. Eur. Respir. J. 2001; 18 69-76. (Pubitemid 32717433)
25. Carrasco G.P., de Miguel D.J., Rejas G.J. et al. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes 2006; 4 31.
26. Michaud C.M., Murray C.J., Bloom B.R. Burden of disease - implications for future research. JAMA 2001; 285 535-539. (Pubitemid 32656319)
27. Lopez A.D., Mathers C.D., Ezzati M. et al. Global burden of disease and risk factors. Washington, D.C. The World Bank, 2006
28. Anthonisen N.R., Wright E.C., Hodgkin J.E. Prognosis in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1986; 133 14-20. (Pubitemid 16189089)
29. Wilkinson T.M., Donaldson G.C., Hurst J.R. et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2004; 169 1298- -1303. (Pubitemid 39571857)
30. Ko F.W., Hui D.S., Lai C.K. Worldwide burden of COPD in high- and low-income countries. Part III. Asia-Pacific studies. Int. J. Tuberc. Lung Dis. 2008; 12 713-717.
31. Anzueto A., Sethi S., Martinez F.J. Exacerbations of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2007; 4 554-564. (Pubitemid 47547851)
32. Jemal A., Ward E., Hao Y. et al. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005; 294 1255- -1259. (Pubitemid 41352114)
33. Mannino D.M., Brown C., Giovino G.A. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am. J. Respir. Crit. Care Med. 1997; 156 814-818. (Pubitemid 27396420)
34. Zielinski J., MacNee W., Wedzicha J. et al. Causes of death in patients with COPD and chronic respiratory failure 19. Monaldi Arch. Chest Dis. 1997; 52 43-47. (Pubitemid 27232210)
35. Sin D.D., Anthonisen N.R., Soriano J.B. et al. Mortality in COPD Role of comorbidities. Eur. Respir. J. 2006; 28 1245-1257.
36. Decramer M., Rennard S., Troosters T. et al. COPD as a lung disease with systemic consequences - clinical impact, mechanisms, and potential for early intervention. COPD 2008; 5 235-256.
37. Johnston A.K., Mannino D.M., Hagan G.W. et al. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax 2008; 63 599-605. (Pubitemid 351969252)
38. Halpin D.M., Miravitlles M. Chronic obstructive pulmonary disease the disease and its burden to society. Proc. Am. Thorac. Soc. 2006; 3 619-623. (Pubitemid 44411630)
39. Mannino D.M., Davis K.J. Lung function decline and outcomes in an elderly population. Thorax 2006; 61 472-477. (Pubitemid 43901515)
40. Bartal M. COPD and tobacco smoke. Monaldi Arch. Chest Dis. 2005; 63 213-225. (Pubitemid 43174175)
41. Seemungal T.A., Donaldson G.C., Bhowmik A. et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2000; 161 1608-1613. (Pubitemid 30329036)
42. Mannino D.M. Epidemiology and global impact of chronic obstructive pulmonary disease. Semin. Respir. Crit. Care Med. 2005; 26 204-210. (Pubitemid 40617297)
43. Schneider A., Gantner L., Maag I. et al. Are ICD-10 codes appropriate for performance assessment in asthma and COPD in general practice? Results of a cross-sectional observational study. BMC Health Serv. Res. 2005; 5 11.
44. Mannino D.M. Should we be using statistics to define disease? Thorax 2008; 63 1031-1032.
45. Cerveri I., Corsico A.G., Accordini S. et al. Underestimation of airflow obstruction among young adults using FEV1/FVC 70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax 2008; 63: 1040-1045.